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Webnesday, February 29, 2012 691aanalyzed by LC/MS/MS. A specific MaxiKa immunoprecipitation is supported
by the identification of peptides covering 27.1% of MaxiKa protein in samples
from wild-type animals and using anti-MaxiKa antibodies but not in samples of
immunoprecipitates using IgG or brains of Kcnma1-/- animals (n=3). MaxiKa
splice variants, STREX (in between exon 18 and 19) and SV27 (in between
exon 23 and 24) as well as two residue variants A632R and F633L in exon
19 were identified (n=3) . In addition to the 21 proteins immunopreciptated
earlier from murine cortical membranes (Gorini et al, FEBS Lett. 2010;
584:845-51), 254 additional proteins were obtained (n=3). Along with theMax-
iKb4 subunit (Kcnmb4), Teneurin 2, Insulin receptor-related protein, Kinesin
21A, Ubiquitin-conjugating enzyme 2N, GABA transporter 3&4 (S6A11),
SERCA 2, Coronin 1A, Citrate synthase, Ssbp2, and Rl19 were identified as
the most prominent proteins interacting with the brain MaxiKa. Several nuclear
and mitochondrial proteins were also detected. These results strongly suggest
that MaxiKa interacts with a variety of proteins in the brain, and further inves-
tigation of functional consequences of these interactions will enhance our un-
derstanding of MaxiK and its role in neuronal function. Supported by NIH and
AHA.
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The renin-angiotensin system (RAS) is a critical regulator of sodium balance,
extracellular fluid volume, vascular resistance, and, ultimately, arterial blood
pressure. The key RAS molecule angiotensin II type 1 receptor (AT1R), and
another major determinant of vascular tone, the large conductance calcium-
activated potassium (BKCa) channel, are both highly expressed in renal arterial
smooth muscle cells (SMCs). Our previous studies in expression systems re-
vealed a physical association between AT1R and BKCa, and that AT1R associ-
ation modified BKCa channel voltage sensitivity. However, the effect of Ang II
on BKCa channels in renal arterial SMCs needs to be defined. Furthermore,
whether AT1R association is critical for the alteration of channel activity in re-
sponse to Ang II, and whether the coupling changes BKCa reactivity to specific
inhibitors also remain unknown. Our present studies in rat renal arterial SMCs
show that application of 100 nM Iberiotoxin (IbTx, a specific BKCa channel
blocker) inhibits whole-cell BKCa currents by 63.0512.5% (n=5). IbTx-
sensitive BKCa currents were reduced by 44.458.7% (n=3) in response to
1 mM Ang II treatment. In AT1R-IRES-BKCa-transfected HEK293T cells, ex-
tracellular application of 1 mM Ang II also suppressed whole-cell BKCa cur-
rents by 19.750.3% (n=3), while this treatment made no significant changes
in cells expressing only BKCa (n=6). IbTx reduced the whole-cell currents by
37.251.9% (n=4) in BKCa-transfected HEK293T cells and 37.7512.5%
(n=5) in AT1R-IRES-BKCa-transfected cells. Paxilline treatment (100 nM)
produced a 66.858.0% (n=3) reduction of BKCa whole-cell currents in
BKCa-transfected HEK293T cells and 65.859.2% (n=3) reduction in AT1R-
IRES-BKCa-transfected cells. These results demonstrate that Ang II inhibits
BKCa channel activity in renal arterial SMCs and suggest that AT1R serves
as the mediator of the effect. However, the interaction between AT1R and
BKCa does not change channel reactivity towards specific channel inhibitors.
Supported by NIH.
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Our previous immunochemical and transcript analyses indicate that the large
conductance calcium-activated potassium channel (BKCa) is present in cardiac
mitochondria and encoded by the Kcnma1 gene. In addition, studies using
a BKCa opener, NS1619, point to the view that opening BKCa expressed in mi-
tochondria (mitoBKCa) contributes to cardioprotection after ischemic insult by-
modulating mitochondrial function. However, whether the beneficial effect of
NS1619 depends on the presence of Kcnma1 has not been studied. To address
this question, we used mice expressing (wild type, wt) or not (Kcnma1-/-)
Kcnma1 gene product and the Langendorff model of global ischemia and reper-
fusion.Mitochondrial functions affecting the opening of the mitochondrial per-
meability transition pore (mPTP) and cell death were assessed: calcium
retention capacity (CRC) and reactive oxygen species (ROS). Mitochondria
were isolated after 10 min of reperfusion from hearts preconditioned or not(control) for 10 min before ischemia with 10 mM NS1619. Mitochondria
from hearts preconditioned with NS1619 showed a significant increase in
CRC from 140þ11 to 280þ23 nmoles/mg (n=3) in wt mice but no significant
effect was observed in Kcnma1-/- mice (120þ23 and 100þ11 nmoles/mg, n=3)
showing that after ischemic insult the protective effect of NS1619 requires ex-
pression of Kcnma1 gene. Likewise, mitochondrial ROS production stimulat-
ing complex I with 3 mM glutamate/malate was reduced by NS1619
preconditioning in the wt mice from 159þ13 to 113þ7 pmoles/min/mg but
not in the Kcnma1-/- mice (n=3). Our results indicate that Kcnma1 gene expres-
sion is required for the improvement of mitochondrial function by NS1619 pre-
conditioning, which involves: 1) increased CRC, and 2) decreased ROS
production of complex I, both events preventing mPTP opening. Further, the
results also confirm that mitoBKCa is encoded by Kcnma1 gene. Supported
by NIH and AHA.
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Kþ channels play key roles in dampening excitability in many types of tissues.
In neurons, the large conductance Ca2þ-activated Kþ (BK) channel inhibits ex-
citability by participating in the fast afterhyperpolarization and limiting neuro-
transmitter release. Paradoxically, BK currents have also been recently linked
to enhancing excitability and seizures. Using a transgenic approach, the dual
nature of BK’s influence on excitability was investigated. In vivo expression
of a gain-of function BK channel alpha subunit (R207Q) recapitulates aspects
of both the excitatory and inhibitory influence of BK currents. The direction of
influence is dependent upon the relative expression level of wildtype and mu-
tant subunits, the resulting BK current activation kinetics, and interaction with
other fast-gated Kþ currents.
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Dystrobrevin is a major component of a dystrophin-associated protein com-
plex (DAPC). It is widely expressed in mammalian tissues including the ner-
vous system, where it is localized to the presynaptic nerve terminal with
unknown function. In a genetic screen for suppressors of a lethargic phenotype
caused by a gain-of-function (gf) isoform of SLO-1 in C. elegans, we isolated
multiple loss-of-function (lf) mutants of the dystrobrevin gene dyb-1. dyb-1(lf)
phenocopied slo-1(lf), causing increased neurotransmitter release at the neuro-
muscular junction, increased frequency of Ca2þ transients in body-wall mus-
cle, and abnormal locomotion behavior. Neuron- and muscle-specific rescue
experiments suggest that DYB-1 is required for SLO-1 function in both neu-
rons and muscle cells. DYB-1 colocalized with SLO-1 at presynaptic sites
in neurons and dense body regions in muscle cells, and dyb-1(lf) caused
SLO-1 mislocalization in both types of cells without altering SLO-1 protein
level. The neuronal phenotypes of dyb-1(lf) were partially rescued by mouse
a-dystrobrevin-1 (aDB1). These observations revealed novel functions of
the BK channel in regulating muscle Ca2þ transients, and of dystrobrevin in
controlling neurotransmitter release and muscle Ca2þ transients by localizing
the BK channel.
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Intermediate-conductance Ca2þ-activated Kþ channel (IKCa channel) encoded
by KCa3.1 is responsible for the control of proliferation and differentiation in
various types of cells. We identified novel spliced variants of KCa3.1
(hKCa3.1b) from the human thymus, which were lacking the N-terminal do-
mains of the original hKCa3.1a as a result of alternative splicing. hKCa3.1b
was significantly expressed in human lymphoid tissues. Western blot analysis
showed that hKCa3.1a proteins were mainly expressed in plasma membrane
fraction, whereas hKCa3.1b was in the cytoplasmic fraction. We also identi-
fied a similar N-terminus lacking KCa3.1 spliced variants from mice and rat
lymphoid tissues (mKCa3.1b, rKCa3.1b). In the HEK293 heterologous
